Gold Nanoparticles Bearing Functional Anti-Cancer Drug and Anti-Angiogenic Agent: A "2 in 1" System with Potential Application in Cancer Therapeutics
Gold Nanoparticles Bearing Functional Anti-Cancer Drug and Anti-Angiogenic Agent: A "2 in 1" System with Potential Application in Cancer Therapeutics
复制标题
DOI:
10.1166/jbn.2005.016
复制
发表时间:
2005-06-01
影响因子:
2.9
通讯作者:
Mukhopadhyay, Debabrata
中科院分区:
文献类型:
--
作者:
Mukherjee, Priyabrata;Bhattacharya, Resham;Mukhopadhyay, Debabrata
Angiogenesis, the formation of new blood vessels from a pre-existing vessel, is a necessary step for tumor growth and metastasis. Combination therapy using anti-angiogenic molecule and cytotoxic agents is a promising approach in anti-cancer therapy. However, the underlying problem in the use of anti-cancer drug is that they have short half-lives with extensive systemic toxicity. However, when delivered in a gold-conjugated form, these molecules might have increased retention in the body with reduced systemic toxicity. In this study a nano-composite system consisting of a nanogold core bearing an anti-angiogenic molecule, VEGF antibody-2C3 (AbVF), along with an anti-cancer drug, gemcitabine has been reported. The physico-chemical characterization of these nanocomposites was performed using UV-Visible (UV-Vis) spectroscopy and transmission electron microscopy (TEM). The functional activity of the individual components in the nanocomposites was tested on HUVEC (human umbilical vein endothelial cells) and 786-O cells and showed retention of functional activity of both VEGF antibody and gemcitabine. This provides a unique "2 in 1" system where 2 components with different functions have been attached onto a single gold core, yet the functional activity of the individual components are retained. These nano-composites might find potential applications in the treatment of cancer.